| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a717ea5b2ac78ac329ab3a9659d834d2 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04 |
| filingDate |
1979-07-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1980-11-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_62733e9225f987e3c147df896e6b5455
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_589cfca9667145c40a828937f7749b77 |
| publicationDate |
1980-11-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-4233445-A |
| titleOfInvention |
7-(Substituted)-7H-pyrrolo[3.2-F]-quinazoline-1,3-diamines |
| abstract |
7-(Substituted)-pyrrolo[3,2-f]quinazoline-1,3-diamines possess antibacterial activity in vitro. The invention also provides compounds having synergism in vivo with sulfa drugs against bacterial infections. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0639075-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0639075-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7226915-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004229890-A1 |
| priorityDate |
1979-07-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |